Atnahs Pharma Denmark ApS
CVR 36699051 · Private limited company (ApS) · Active · Low risk
Atnahs Pharma Denmark ApS is a Private limited company (ApS), founded on , based in København S. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.4% over the next 12 months, which is 0.3 times the average for Danish companies. 11 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK 2.1m and a net result of DKK 12k. CEO: Christoph Michael Habereder.
Bankruptcy risk for Atnahs Pharma Denmark ApS
0.3 × the average (1.41%) · higher risk than 57% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 36699051
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (11 years)
- Address
- c/o Pharmanovia A/S, Ørestads Boulevard 108, 5. tv
2300 København S - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 50k
- Auditor
- CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 3 of 11 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 6.3% |
| Current ratio | 108% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 10 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 18 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | DKK 52.6m | DKK 71.4m | DKK 90.5m |
| Gross profit | DKK -1.6m | DKK 1.4m | DKK 925k |
| Net profit | DKK 12k | DKK 48k | DKK 39k |
| Equity | DKK 2.1m | DKK 2.1m | DKK 2.0m |
| Total assets | DKK 33.1m | DKK 51.2m | DKK 68.0m |
| Cash | DKK 224k | DKK 2.0m | – |
| Short-term debt | DKK 30.4m | DKK 47.4m | – |
| Tax owed | DKK 0 | DKK 569k | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class C, stor virksomhed · auditor's statement: Revisionspåtegning · Christensen Kjærulff, STATSAUTORISERET REVISIONSAKTIESELSKAB.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Apr 2025 – 31 Mar 2026 | 183 | ||
| 1 Apr 2024 – 31 Mar 2025 | 216 | Late | |
| 1 Apr 2023 – 31 Mar 2024 | 218 | Late | |
| 1 Apr 2022 – 31 Mar 2023 | 189 | Late | |
| 1 Apr 2021 – 31 Mar 2022 | 155 | ||
| 1 Apr 2020 – 31 Mar 2021 | 167 | ||
| 1 Apr 2019 – 31 Mar 2020 | 141 | ||
| 1 Apr 2018 – 31 Mar 2019 | 130 | ||
| 1 Apr 2017 – 31 Mar 2018 | 139 | ||
| 1 Jan 2016 – 31 Mar 2017 | 153 | ||
| 27 Mar 2015 – 31 Dec 2015 | 160 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Christoph Michael Habereder | Current | |
| CEO | Lisbet Johansen | ||
| CEO | Svend Aage Johansen | ||
| CEO | Amit Vijaykumar Patel | ||
| CEO | James Sang Bum Lee | ||
| CEO | Neeshe Bhikhubhai Williams | ||
| Board | Twan Johannes Anna Nouwen | Current | |
| Board | Christoph Michael Habereder | Current | |
| Board | Mohammad Muqtadir Samy | Current | |
| Board | Svend Aage Johansen | ||
| Board | Amit Vijaykumar Patel | ||
| Board | Dipen Vijaykumar Patel | ||
| Board | Anthony Charles Playle | ||
| Board | Mark John Cotterill | ||
| Board | Svend Aage Johansen | ||
| Board | Neeshe Bhikhubhai Williams | ||
| Board | Rishi Bhikhu | ||
| Board | Alastair Thomas Badgett Hay | ||
| Board | Jesper Wilhelm Voss | ||
| Board | Felipe Andres Florez Arango | ||
| Board | James Charles Burt | ||
| Board | James Sang Bum Lee | ||
| Board | Santsagar Patel | ||
| Board | Zubair Javeed | ||
| Board | Mohammad Muqtadir Samy | ||
| Owner (100%) | Atnahs Pharma UK Limited | Current | |
| Owner (100%) | Java Holding ApS | ||
| Owner (33%) | Java Holding ApS | ||
| Owner (50%) | Atnahs Pharma UK Limited | ||
| Owner (33%) | Svend Aage Johansen | ||
| Auditor | CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB | Current | |
| Auditor | KPMG P/S | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Java Holding ApS | Current |
The CEOs' other companies
Lisbet Johansen – 3 other companies
- CHRISJOPALI ApS Active
- Java Holding ApS Opløst
- MEDICAL MATCH A/S Active
Svend Aage Johansen – 17 other companies
- ANESTIC ApS Compulsorily dissolved
- BECKETT INVEST ApS Compulsorily dissolved
- BIO RESEARCH A/S Opløst
- CCURE A/S Active
- CHR. OLESEN PHARMACEUTICALS A/S Active
- CHR. OLESEN SYNTHESIS A/S Active
- DLI - DANSK LÆGEMIDDEL INFORMATION A/S Active
- ETHNOCINE ApS Opløst
- INFORMEDICA A/S Compulsorily dissolved
- MEDIC TEAM A/S Fusioneret
- MEDICAL MATCH A/S Active
- MERCK A/S Opløst
- NM AF 18. JUNI 2009 A/S Active
- NORDMEDICA A/S Active
- Pharmanovia A/S Active
- TPR-GROUP ApS Active
- Øresund Pharma ApS Active
James Sang Bum Lee – 1 other companies
- Pharmanovia A/S Active
Address history (4 moves)
| c/o Pharmanovia A/S, Ørestads Boulevard 108, 5. tv, 2300 København S | |
| c/o Pharmanovia A/S, Jægersborg Alle 164, 2820 Gentofte | |
| Sundvænget 10, 2900 Hellerup | |
| c/o Lisbet og Svend Johansen, Hambros Alle 3, 2900 Hellerup | |
| c/o Lisbet og Svend Johansen, Hambros Alle 2, 2900 Hellerup |
Former names
| Atnahs Pharma Denmark ApS | – now |
| Pharmamentum ApS | – |
Other companies at the same address
- COMCARE A/S Fusioneret
- Cellnex Denmark ApS Active
- ERICSSON DANMARK A/S Active
- Finest Cask ApS Active
- Intellis A/S Active
- On Tower Denmark ApS Active
- PHILIP MORRIS ApS Active
- PIXLAB A/S Active
- Pharmanovia A/S Active
- Punktum dk A/S Active
- S. LARSEN HOLDING ApS Active
- STANDOUT A/S Active
- Standoutmedia Holding ApS Active
- TENET A/S Active
- Tetra Pharm Technologies ApS Active
- Tetrapharm Bioengineering ApS Active
- Tetrapharm Therapeutics ApS Active
- iBridge Consulting ApS Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about Atnahs Pharma Denmark ApS
Has Atnahs Pharma Denmark ApS gone bankrupt?
No, Atnahs Pharma Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Atnahs Pharma Denmark ApS?
Our model estimates a bankruptcy risk of 0.4% over the next 12 months (low risk), which is 0.3 times the average for Danish companies.
Who is the CEO of Atnahs Pharma Denmark ApS?
Christoph Michael Habereder is the CEO of Atnahs Pharma Denmark ApS.
Who is the auditor of Atnahs Pharma Denmark ApS?
Atnahs Pharma Denmark ApS most recently used CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB.
When was Atnahs Pharma Denmark ApS founded?
Atnahs Pharma Denmark ApS was founded on 27 March 2015.
What is the equity of Atnahs Pharma Denmark ApS?
Equity was DKK 2.1m according to the annual report for the period ending 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.